Evaluation of the Effectiveness of Two Morphine Protocols to Treat Neonatal Abstinence Syndrome in a Level II Nursery in a Community Hospital.

Abstract:

:The authors sought to evaluate the impact on length of hospital stay and treatment duration of morphine after implementation of a change in the institutional protocol for managing neonatal abstinence syndrome (NAS) in an effort to improve patient outcomes. A single-center, retrospective chart review was conducted at a Level II nursery in a community hospital in Kentucky. Fifty-nine neonates born between January 1, 2014, and December 31, 2015, who were diagnosed with NAS and received morphine for treatment were included. The protocol 1 group consisted of 33 neonates who received an initial dose of morphine 0.04 mg/kg/dose administered orally every 4 hours (January 1-December 31, 2014), and the protocol 2 group consisted of 26 neonates who received an initial dose of morphine 0.06 mg/kg/dose administered orally every 3 hours (January 1-November 30, 2015), after a change in the protocol for managing NAS was implemented on January 1, 2015. Data were reviewed and compared between the two protocol groups to determine the impact that the dosage change had on length of hospital stay and morphine treatment duration. The average length of stay decreased by 7 days in the protocol 2 group compared with the protocol 1 group (21 vs 28.65 days). The average duration of treatment decreased by 7 days in the protocol 2 group compared with the protocol 1 group (18.3 vs 25.4 days). These differences between groups were not statistically significant, however, because the population size was not large enough to achieve adequate power. These results indicate that protocol 2 displayed the potential to decrease length of stay and duration of treatment compared with protocol 1 at this facility; however, balancing higher starting doses with the risk of oversedation will continue to challenge the health care team. Concern for oversedation when using the higher starting dose in protocol 2 has prompted further research (e.g., protocol 3, initial morphine 0.05 mg/kg/dose every 3 hrs). Continued research is also necessary with larger patient populations to enable generalizability to other institutions.

journal_name

Pharmacotherapy

journal_title

Pharmacotherapy

authors

DeAtley HN,Burton A,Fraley MD,Haltom J

doi

10.1002/phar.1966

subject

Has Abstract

pub_date

2017-07-01 00:00:00

pages

856-860

issue

7

eissn

0277-0008

issn

1875-9114

journal_volume

37

pub_type

杂志文章
  • Clostridium difficile-associated disease: an emerging threat to patient safety: insights from the Society of Infectious Diseases Pharmacists.

    abstract::A formerly infrequently isolated strain of Clostridium difficile known as BI/NAP1 has resulted in geographically diverse outbreaks of C. difficile-associated disease. Such rapid dissemination and distribution of an outbreak strain of C. difficile are unprecedented, with many regions across North America, as well as se...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.26.3.299

    authors: Owens RC

    更新日期:2006-03-01 00:00:00

  • Severe withdrawal syndrome possibly associated with cessation of a midazolam and fentanyl infusion.

    abstract::A 40-month-old child was sedated with a fentanyl and midazolam infusion for 7 days. After the drugs were discontinued he became unresponsive and globally aphasic, and had marked thrombocytosis. He was hospitalized for 4 weeks, during which time his motor and cognitive status slowly improved, and had almost returned to...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/j.1875-9114.1995.tb02877.x

    authors: Ducharme MP,Munzenberger P

    更新日期:1995-09-01 00:00:00

  • Updates in hormonal emergency contraception.

    abstract::In recent years, there have been many updates in hormonal emergency contraception. Levonorgestrel emergency contraception has been available for several years to prevent pregnancy when used within 72 hours after unprotected intercourse or contraceptive failure, and it was recently approved for nonprescription status f...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.31.9.887

    authors: Shrader SP,Hall LN,Ragucci KR,Rafie S

    更新日期:2011-09-01 00:00:00

  • Guidelines for using darbepoetin alfa in patients with chemotherapy-induced anemia.

    abstract::Anemia is an undertreated but common complication of cancer and is associated with debilitating symptoms that impair the patient's ability to perform daily functions of life. Treatment with darbepoetin alfa, a novel erythropoiesis-stimulating protein, is appropriate for chemotherapy-induced anemia. Guidelines on darbe...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.23.16.110s.31970

    authors: Bloomfield M,Jaresko G,Zarek J,Dozier N

    更新日期:2003-12-01 00:00:00

  • Microbiologic surrogate end points in clinical trials of infectious diseases: example of acute otitis media trials.

    abstract::Clinical outcomes that measure how patients feel, function, or survive are the most important and relevant outcomes of therapy in clinical trials and in clinical practice. Surrogate end points, which do not directly measure clinical benefit to the patient, may function as substitutes for clinical end points in clinica...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.2005.25.12part2.109S

    authors: Powers JH

    更新日期:2005-12-01 00:00:00

  • 1995 National Clinical Pharmacy Services Study.

    abstract::To determine the extent of hospital-based clinical pharmacy services in 1995, we surveyed 1109 United States acute care, general, medical-surgical, and pediatric hospitals with 50 or more licensed beds. Fifteen clinical pharmacy services were assessed to determine pharmacists' specific patient care responsibilities. T...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Raehl CL,Bond CA,Pitterle ME

    更新日期:1998-03-01 00:00:00

  • Acute hepatic failure associated with oral minocycline: a case report.

    abstract::A 39-year-old woman was evaluated for possible liver transplantation due to rapidly developing hepatic failure 4 weeks after initiation of oral minocycline 100 mg twice a day for the treatment of acne. The patient developed a maculopapular rash, malaise, fever, nausea, and vomiting 2 weeks prior to admission to the ho...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Min DI,Burke PA,Lewis WD,Jenkins RL

    更新日期:1992-01-01 00:00:00

  • Fluconazole-induced agranulocytosis with eosinophilia.

    abstract::Fluconazole is a commonly prescribed antifungal agent with a favorable safety profile. A patient experienced agranulocytosis and eosinophilia associated with the drug. Similar bone marrow-suppressive effect due to the azoles is rarely described in the English-language literature. ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.20.5.484.35058

    authors: Wong-Beringer A,Shriner K

    更新日期:2000-04-01 00:00:00

  • Postinduction carbamazepine clearance in an adult psychiatric population.

    abstract::The objective of this study was to describe the postinduction clearance of carbamazepine (CBZ) in adult psychiatric patients by population pharmacokinetic analysis using the NONMEM program. Specifically, an estimate of CBZ clearance and insight into the effect of common patient characteristics on clearance were sought...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Martin ES 3rd,Crismon ML,Godley PJ

    更新日期:1991-01-01 00:00:00

  • Olanzapine-associated neuroleptic malignant syndrome in a patient receiving concomitant rivastigmine therapy.

    abstract::Neuroleptic malignant syndrome (NMS) is an idiosyncratic and uncommon but serious adverse effect that has been reported with both typical and atypical antipsychotic agents. We describe a 58-year-old man with Down syndrome and dementia who was receiving low-dose olanzapine and rivastigmine therapy; he developed NMS 4 m...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.28.3.403

    authors: Stevens DL,Lee MR,Padua Y

    更新日期:2008-03-01 00:00:00

  • Impact of Sodium-Glucose Cotransporter 2 Inhibitors on Nonglycemic Outcomes in Patients with Type 2 Diabetes.

    abstract::The efficacy of the sodium-glucose cotransporter 2 (SGLT2) inhibitors canagliflozin, dapagliflozin, and empagliflozin in reducing hyperglycemia in patients with type 2 diabetes is well documented. In addition, positive effects have been observed with these agents on nonglycemic variables, such as reductions in body we...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.1903

    authors: Trujillo JM,Nuffer WA

    更新日期:2017-04-01 00:00:00

  • More stable and reliable pharmacokinetics with preprandial administration of cyclosporine compared with postprandial administration in patients with refractory nephrotic syndrome.

    abstract:STUDY OBJECTIVE:To compare the absorption profile of cyclosporine after preprandial administration with that after postprandial administration, and to determine which administration time resulted in a more stable absorption profile and the timing of the drug concentration that was the most reliable marker for monitorin...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.25.1.52.55617

    authors: Kusaba T,Konno Y,Hatta S,Fujino T,Yasuda T,Miura H,Sasaki H,Okabayashi J,Murao M,Sakurada T,Imai G,Shirai S,Kuboshima S,Shima Y,Ogimoto G,Sato T,Masuhara K,Kimura K

    更新日期:2005-01-01 00:00:00

  • Quality of anticoagulation care in patients discharged from a pharmacist-managed anticoagulation clinic after stabilization of warfarin therapy.

    abstract:STUDY OBJECTIVE:To determine if transitioning patients from a pharmacist- managed anticoagulation clinic after stabilization of warfarin therapy to physician-managed care alters the quality of anticoagulation care. DESIGN:Retrospective medical record review. SETTING:Pharmacist-managed, urban academic medical center-b...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.28.1.20

    authors: Garwood CL,Dumo P,Baringhaus SN,Laban KM

    更新日期:2008-01-01 00:00:00

  • Pharmacoepidemiology II: the nested case-control study--a novel approach in pharmacoepidemiologic research.

    abstract::This article on pharmacoepidemiology, the second of two parts, is a more focused discussion of the methodology of cohort studies and case-control studies, the basic methodologies of which were discussed in part I. The nested case-control study incorporates the strengths of both the cohort and case-control studies but ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.24.13.1105.38083

    authors: Etminan M

    更新日期:2004-09-01 00:00:00

  • Management of venous thromboembolism and the potential to impact overall survival in patients with cancer.

    abstract::The risk of venous thromboembolism (VTE) in patients with cancer is 6-12-fold higher than in the general population, and VTE is the second leading cause of death in this population, after cancer itself. The etiology underlying the increased risk of VTE is multifactorial and complex, involving patient-, tumor-, and tre...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.29.11.1344

    authors: Saraiya B,Goodin S

    更新日期:2009-11-01 00:00:00

  • The Relationship between the Initial Anti-factor Xa Measurement and the Duration of Direct Oral Anticoagulant Influence in Patients Transitioning to Heparin.

    abstract:BACKGROUND:Anticoagulation monitoring during transition from direct oral anticoagulants (DOAC) to heparin infusions is a significant challenge. Factor Xa inhibitors influence the heparin calibrated antifactor Xa assay. The University of Virginia (UVA) Medical Center utilized a corrected antifactor Xa assay (c-AXA) duri...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.2444

    authors: Plum MD,Hedrick JN,Hockman R,Bazydlo L,Palkimas S

    更新日期:2020-09-01 00:00:00

  • Pharmacokinetics of intravenous trovafloxacin in critically ill adults.

    abstract::The pharmacokinetic disposition of numerous antimicrobial agents is altered in critically ill patients. Pharmacokinetics of trovafloxacin, a fluoroquinolone indicated specifically for severe, life-threatening infections in the intensive care unit, have not been well studied in this population. We characterized the pha...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1592/phco.20.5.400.35056

    authors: Olsen KM,Rebuck JA,Weidenbach T,Fish DN

    更新日期:2000-04-01 00:00:00

  • Key articles and guidelines for the prevention of venous thromboembolism.

    abstract::Venous thromboembolism (VTE) is an important medical problem that affects millions of patients each year. With appropriate prophylaxis, many of these thromboembolic events can be prevented. Although strong evidence supporting VTE prophylaxis spans several decades, several large American and global registries have docu...

    journal_title:Pharmacotherapy

    pub_type:

    doi:10.1592/phco.29.4.410

    authors: Dobesh PP,Wittkowsky AK,Stacy Z,Dager WE,Haines ST,Lopez LM,Nutescu E,Phillips KW,Trujillo TC,Vondracek T

    更新日期:2009-04-01 00:00:00

  • Comparison of two methods for INR determination in a pharmacist-based oral anticoagulation clinic.

    abstract::Warfarin is a commonly used oral anticoagulant that is usually initiated after the definitive diagnosis of a certain thromboembolic disorder or disease. Warfarin therapy will usually be prescribed for 6-12 weeks or more, and some patients may continue therapy throughout life, depending on the type of thromboembolic di...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章

    doi:

    authors: Yamreudeewong W,Johnson JV,Cassidy TG,Berg JT

    更新日期:1996-11-01 00:00:00

  • Health outcomes and economic impact of therapy conversion to a biphasic insulin analog pen among privately insured patients with type 2 diabetes mellitus.

    abstract:STUDY OBJECTIVE:To evaluate claims-related treatment adherence, health care resource utilization, and associated costs of therapy conversion from an insulin vial and syringe to a premixed biphasic insulin analog pen device among privately insured patients with type 2 diabetes mellitus. DESIGN:Retrospective, longitudin...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.27.7.948

    authors: Cobden D,Lee WC,Balu S,Joshi AV,Pashos CL

    更新日期:2007-07-01 00:00:00

  • Early-onset pentamidine-associated second-degree heart block and sinus bradycardia: case report and review of the literature.

    abstract::Although various manifestations of pentamidine-induced cardiotoxicity have been reported, to our knowledge, second-degree heart block associated with this agent has not been described. In addition, cardiac adverse effects usually develop after at least 6 days of therapy. We describe a 54-year-old, human immunodeficien...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.2005.25.6.899

    authors: Antoniou T,Gough KA

    更新日期:2005-06-01 00:00:00

  • Atracurium resistance in a critically Ill patient.

    abstract::A previously healthy 25-year-old man with metastatic testicular teratocarcinoma became resistant to atracurium-induced neuromuscular blockade as evidenced by train-of-four (TOF) monitoring combined with clinical assessment. Subsequently he had an adequate response with a standard dosage of pancuronium. During the firs...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Tschida SJ,Hoey LL,Nahum A,Vance-Bryan K

    更新日期:1995-07-01 00:00:00

  • Efficacy and safety of low-dose valganciclovir for prevention of cytomegalovirus disease in renal transplant recipients: a single-center, retrospective analysis.

    abstract:STUDY OBJECTIVE:To evaluate the safety and efficacy of valganciclovir 450 mg/day for 6 months for cytomegalovirus (CMV) prophylaxis in renal transplant recipients. DESIGN:Single-center, retrospective analysis. SETTING:Urban, academic medical center. PATIENTS:Fifty-eight patients who received de novo renal transplant...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.24.14.1323.43152

    authors: Gabardi S,Magee CC,Baroletti SA,Powelson JA,Cina JL,Chandraker AK

    更新日期:2004-10-01 00:00:00

  • Vitamin K-independent warfarin resistance after concurrent administration of warfarin and continuous enteral nutrition.

    abstract:STUDY OBJECTIVE:To assess the influence of withholding continuous enteral nutrition for 1 hour before and after warfarin administration compared with the coadministration of warfarin with continuous enteral nutrition on changes in international normalized ratios (INRs). DESIGN:Retrospective, crossover case series. SE...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.28.3.308

    authors: Dickerson RN,Garmon WM,Kuhl DA,Minard G,Brown RO

    更新日期:2008-03-01 00:00:00

  • Methotrexate in rheumatoid arthritis: an update.

    abstract::Methotrexate, a folic acid antagonist, is being employed more frequently in an attempt to control rheumatoid arthritis that has not responded adequately to conventional therapies. Systemic administration of 7.5-15 mg weekly in a pulse fashion appears to be effective without precipitating serious adverse effects. Conce...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/j.1875-9114.1986.tb03472.x

    authors: Miller DR,Letendre PW,DeJong DJ,Fiechtner JJ

    更新日期:1986-07-01 00:00:00

  • Is there a risk of bleeding associated with standardized Ginkgo biloba extract therapy? A systematic review and meta-analysis.

    abstract:STUDY OBJECTIVE:To determine the effect of standardized Ginkgo biloba leaf extracts (GBE) on outcome parameters of hemostasis associated with risk of bleeding. DESIGN:Meta-analysis of 18 randomized controlled trials. SUBJECTS:A total of 1985 adults were enrolled to receive either GBE or placebo; 87% were patients wit...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,meta分析,评审

    doi:10.1592/phco.31.5.490

    authors: Kellermann AJ,Kloft C

    更新日期:2011-05-01 00:00:00

  • Bacterial resistance to beta-lactams, and its prevention with combination antimicrobial therapy.

    abstract::The clinical and economic impacts of bacterial resistance are substantial. The development of bacterial resistance during a course of therapy often leads to clinical failure, prolonged hospitalization, increased morbidity, mortality, and increased health care costs. Resistance has been reported to occur most frequentl...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:

    authors: Barriere SL

    更新日期:1992-01-01 00:00:00

  • Emerging role of capecitabine in gastric cancer.

    abstract::For many years, a regimen of fluorouracil and cisplatin has been the standard of care for the treatment of patients with metastatic gastric cancer. More recently, triplet regimens that incorporate fluorouracil and cisplatin with epirubicin (ECF) or docetaxel are being used in the management of patients with metastatic...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.29.3.318

    authors: Comella P,Franco L,Casaretti R,de Portu S,Menditto E

    更新日期:2009-03-01 00:00:00

  • Drug and poison information resources on the Internet, Part 1: An introduction.

    abstract::The Internet is an excellent source of drug and poison information. Despite the relative case and minimal costs associated with accessing the Internet, many pharmacists and other health care professionals have been slow to adopt this new technology. ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Marra CA,Lynd LD,McKerrow R,Carleton BC

    更新日期:1996-07-01 00:00:00

  • Granulocyte-macrophage colony-stimulating factor and zidovudine in the treatment of neutropenia and human immunodeficiency virus infection.

    abstract::Granulocyte-macrophage colony-stimulating factor (GMCSF) is a hematopoietic protein that has been studied both in vitro and in vivo in human immunodeficiency virus (HIV) infection. Since both HIV infection primarily and zidovudine (formerly AZT) treatment secondarily may result in neutropenia, administration of GMCSF ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:

    authors: Hewitt RG,Morse GD

    更新日期:1992-01-01 00:00:00